Filaricidal efficacy of anthelmintically active cyclodepsipeptides
Filaricidal efficacy of anthelmintically active cyclodepsipeptides
复制标题
DOI:
10.1016/s0020-7519(01)00263-6
复制
发表时间:
2001-11-01
影响因子:
4
通讯作者:
von Samson-Himmelstjerna, G
中科院分区:
文献类型:
--
作者:
Zahner, H;Taubert, A;von Samson-Himmelstjerna, G
PF 1022A. a novel anthelmintically active cyclodepsipeptide, and Bay 44-4400, a semisynthetic derivative of PF 1022A were tested for filaricidal efficacy in Mastomys concha infected with Litomosoides sigmodontis, Acanthocheilonema viteae and Brugia malayi. The parent compound PF 1022A showed limited anti-filarial efficacy in L. sigmodontis and B. malayi infected animals. Oral doses of 5 x 100 mg/kg on consecutive days caused only a temporary decrease of microfilariaemia levels. By contrast, Bay 44-4400 was highly effective against microfilariae of all three species in single oral, subcutaneous and cutaneously applied (spot on) doses. Minimum effective doses (MED, reducing parasitaemia density by greater than or equal to 95%) determined 3 and 7 days after treatment were 3.125-6.25 and 6.25-12.5 mg/kg, respectively. Using the spot on formulation, doses of 6.25 mg/kg (L. sigmodontis), 12.5 mg/kg (A. viteae) and 25 mg/kg (B. malayi) were required to cause reductions of microfilaraemia levels by greater than or equal to 95% until day 56. Adulticidal effects, determined as minimum curative doses (MCD, eliminating adult parasites within 56 days by >95%) after single dose treatment were limited to A. viteae (MCD, 100 mg/kg independent of the route of administration). Repeated oral treatment (100 mg/kg on 5 consecutive days) killed all adult L. sigmodontis but did not affect B. malayi. However, single doses of 6.25 and 25 mg/kg resulted in severe pathological alterations of intrauterine stages of L. sigmodontis and B. malayi, respectively. These alterations may be responsible for long-lasting reductions of microfilaraemia even when curative effects could not be achieved. (C) 2001 Australian Society for Parasitology Inc. Published by Elsevier Science Ltd. All rights reserved.